Star-Shaped Peptide Polymers for Antibacterial Membrane Disruption
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current antibacterial agents are ineffective against Gram-negative bacteria due to their outer membrane and drug efflux pumps, leading to antibiotic resistance and limited treatment options for infections caused by pathogens like Pseudomonas aeruginosa and Acinetobacter baumannii.
Innovation Solution
Development of star-shaped peptide polymers (SNAPPs) with a multifunctional core and statistical or random peptide copolymers as terminal arms, which interact with bacterial membranes to disrupt their integrity and induce apoptotic-like death.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat Gram-negative bacteria, then treatment of Gram-positive bacteria is effective, but Gram-negative bacteria exhibit intrinsic resistance due to outer membrane and efflux pumps
Solution Approach 1:
The invention segments the antibacterial function into two distinct components: (1) membrane-active cationic peptide polymers that disrupt the outer membrane and cytoplasmic membrane of Gram-negative bacteria, and (2) beta-lactam antibiotics that target cell wall synthesis. This segmentation allows the cationic polymers to overcome the outer membrane barrier and efflux pump resistance, delivering the beta-lactam antibiotic to its target site where it can effectively inhibit bacterial growth.
Solution Approach 2:
The cationic peptide polymer acts as an intermediary that facilitates the delivery of beta-lactam antibiotics to Gram-negative bacteria. The polymer first interacts with and disrupts the outer membrane, creating permeability that allows the beta-lactam antibiotic to penetrate into the bacterial cell. This intermediary action overcomes the intrinsic resistance mechanisms (outer membrane and efflux pumps) that normally prevent antibiotic entry.
2Reliability
If antimicrobial peptides are used to combat MDR bacteria, then resistance development is reduced, but toxicity towards mammalian cells increases
Solution Approach 1:
The invention optimizes the parameters of the cationic peptide polymer, specifically the charge density, molecular weight, and amino acid composition (rich in lysine and arginine with hydrophobic residues). These parameter changes enhance selectivity: the polymers have sufficient cationic charge to interact with negatively charged bacterial membranes while maintaining solubility and reducing non-specific binding to mammalian cells. The hydrophobic content is optimized to enable membrane disruption of bacteria without excessive toxicity to mammalian cells.
Solution Approach 2:
The invention creates a composite therapeutic system combining cationic peptide polymers with beta-lactam antibiotics. The cationic polymer component provides membrane disruption and antibiotic delivery, while the beta-lactam component provides specific antibacterial action. This composite approach allows the use of lower concentrations of the cationic polymer than would be needed if used alone, thereby reducing toxicity while maintaining effectiveness against MDR bacteria.
3Adaptability or versatility
If new antibacterial agents are developed to treat Gram-negative infections, then treatment options increase, but development complexity and time increase
Solution Approach 1:
The cationic peptide polymer exhibits multi-functionality: (1) it disrupts the outer membrane of Gram-negative bacteria, (2) it facilitates penetration of beta-lactam antibiotics through the outer membrane, and (3) it maintains stability in physiological conditions. This multi-functionality is achieved through the universal design principle of using cationic amino acid sequences that naturally interact with negatively charged bacterial membranes, a mechanism that works across different Gram-negative bacterial species without requiring species-specific optimization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
SNAPPs demonstrate superior antibacterial activity against both Gram-negative and Gram-positive bacteria, including antibiotic-resistant strains, with a high therapeutic index and reduced likelihood of resistance development.
Implementation Method 1
AMPs interact with microbial membranes through electrostatic interactions and physically damage the bacterial morphology
Data Source
AI summary
This invention relates to antibacterial compounds and compositions thereof. The invention also relates to the use of the compounds and compositions in methods of treating bacterial infections, particularly those bacterial infections including bacteria that exhibit antibiotic resistance. More specifically, the present invention provides a star shaped peptide polymer comprising a multifunctional core with a plurality of terminal arms extending therefrom, wherein the terminal arms are statistical or random peptide copolymers of at least a cationic amino acid residue and a hydrophobic amino acid residue.